Kerala

AOC

Goods

Medicines

e-Tender for the Procurement of Anti Haemophilia Drugs for the year 2025-26

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 8 Oct 202525 Sept 2025Closed

Timeline

Published15 Sept 2025
Closed8 Oct 2025
Technical Evaluation18 Dec 2025
Awarded8 Jun 2026

Bids

Item Wise

5 Bids8 Jun 2026

#	Company	Amount	Rank	Status
1	Intas Pharmaceuticals Ltd. L1₹1 LAccepted-AOC CORPORATE HOUSE NEAR SOLA BRIDGE S G HIGHWAY THALTEJ AHMEDABAD GUJARAT 380054 \| AHMADABAD \| GUJARAT \| 380054	₹1 L	L1	Accepted-AOC DETAILS IN NOTICE
2	Novo Nordisk India Private Limited l1₹1 LAccepted-AOC 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 \| BANGALORE \| BANGALORE \| KARNATAKA \| 560045	₹1 L	l1	Accepted-AOC DETAILS IN NOTICE
3	TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED L1₹1 LAccepted-AOC 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 \| GURUGRAM \| HARYANA \| 122002	₹1 L	L1	Accepted-AOC DETAILS IN NOTICE
4	Grifols India Healthcare Private Limited NO L1Rejected-AOC	-	NO L1	Rejected-AOC DETAILS IN NOTICE
5	ICHOR BIOLOGICS PRIVATE LIMITED Rejected-Technical	-	-	Rejected-Technical Details in notice

BoQ Comparative

Line Items (4)

Sl No	Description	Qty	Unit	Intas Pharmaceuticals Ltd. L2	TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED L3	Grifols India Healthcare Private Limited L1	Novo Nordisk India Private Limited L4
1.00	ANTI HAEMOPHILIC FACTOR VIII with VON WILLIBRAND FACTOR 250 IU (contains Factor VIII 250 IU along with minimum 50% of VWF)	1,700	1 No	-	2,499 ₹2,623.95	6.5 ₹6.83 Lowest	-
2.00	ANTI HAEMOPHILIC FACTOR VII 1 mg (50,000 IU)	500	1 No	-	-	-	38,027 ₹39,928.35 Lowest
3.00	HUMAN ANTI HAEMOPHILIC FACTOR IX 500IU/600 IU	4,500	1 No	3,894 ₹4,088.7 Lowest	4,920 ₹5,166	-	-
4.00	FACTOR VIII INHIBITOR BYPASSING AGENT (FEIBA) 500 U	1,000	1 No	-	30,000 ₹31,500 Lowest	-	-

Corrigenda

Corrigendum

1 updatesLatest on 25 Sept 2025Submission Ends:25 Sept 20258 Oct 2025

Date changes

Download Ends25 Sept 20258 Oct 2025Clarification Ends25 Sept 20258 Oct 2025Submission Ends25 Sept 20258 Oct 2025Bid Opening27 Sept 202510 Oct 2025

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

8 Oct 2025, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL, THYCAUD

Work Description

e-Tender for the Procurement of Anti Haemophilia Drugs for the year 2025-26

Tender Information

Tender ID

2025_KMSCL_797506_1

Reference Number

KMSCL/ED/HAEM/RC/2025/023

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Wise

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

31 documents required · 31 mandatory

Fee/PreQual/Technical

RequiredChecklist in Annexure (.pdf)

RequiredThe details of offline EMD as DD/BG, if applicable (.pdf)

RequiredThe details of Re-inspection fee as per sl no 3 of Anx 1 (.pdf)

RequiredThe details of factory inspection fee as per sl no 4 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 5 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 6 of Anx 1 (.xls)

RequiredNotary attested copy of Average Annual turn over statement as per sl no 7 of Anx 1 (.pdf)

RequiredNotary attested copy of manufacturing license as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested photocopies of valid import license as per slno 9 of Anx 1 (.pdf)

RequiredNotary attested copy of product wise market standing certificate as per sl no 10 of Anx 1 (.pdf)

Requirednotary attested copy of valid license for the sale of drugs imported as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of valid COPP certificate as per sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant document as per sl no 14 of Anx 1 (.pdf)

RequiredNotary attested copy of statment on the method adopted as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant documents on viral detection as per sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of statement on the viral detection as per sl no 17 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant document a sper sl no 18 of Anx 1 (.pdf)

RequiredNotary attested copy of statement on purity of the offered product as per sl no 19 of Anx 1 (.pdf)

RequiredNotary attested copy of relevant document as per sl no 20 of Anx 1 (.pdf)

RequiredNotary attested copy of details of batches tested in NIB as per sl no 21 of Anx 1 (.pdf)

RequiredNotary attested copy of statement as per sl no 22 of Anx 1 (.pdf)

RequiredNotary attested documents to prove the supply as per sl no 23 of Anx 1 (.pdf)

RequiredNotary attested copy of current Non conviction certificate as per sl no 24 of Anx 1 (.pdf)

RequiredNotary attested statement of manufacturer as per sl no 25 of Anx 1 (.pdf)

RequiredNotary attested copy of Power of Attorney as per sl no 26 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 27 of Anx 1 (.pdf)

RequiredNotary attested copy of Audited Balance sheets as per sl no 28 of Anx 1 (.pdf)

RequiredNotary attested details of technical personnel as per sl no 29 of Anx 1 (.pdf)

RequiredNotary attested details of the bidder as per sl no 30 of Anx 1 (.pdf)

RequiredNotary attested copy of valid WHO GMP certificate as per sl no 12 of Anx 1 (.pdf)

Finance

RequiredPrice bid format (.xls)

Fee & Financial Details

Tender Fee Amount

₹29,500

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

8 Jun 2026

Published

15 Sept 2025

Bid Opening

10 Oct 2025

Download Starts

15 Sept 2025

Download Ends

8 Oct 2025

Submission Starts

15 Sept 2025

Clarification Period

15 Sept 2025 - 8 Oct 2025

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.05 MB

Technical Evaluation

tech_eval.pdf

PDF

Financial Bid Opening

boq_comp_chart.xlsx

xlsx

Financial Evaluation

fin_eval.pdf

PDF

Award of Contract

aoc.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Company

Intas Pharmaceuticals Ltd.

L1₹1 LAccepted-AOC

CORPORATE HOUSE NEAR SOLA BRIDGE S G HIGHWAY THALTEJ AHMEDABAD GUJARAT 380054 | AHMADABAD | GUJARAT | 380054

Novo Nordisk India Private Limited

l1₹1 LAccepted-AOC

1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045

TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED

L1₹1 LAccepted-AOC

6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002

Grifols India Healthcare Private Limited

NO L1Rejected-AOC

ICHOR BIOLOGICS PRIVATE LIMITED

Rejected-Technical

Sl No

Description

Qty

Unit

Intas Pharmaceuticals Ltd.

TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED

Grifols India Healthcare Private Limited

Novo Nordisk India Private Limited

1.00

ANTI HAEMOPHILIC FACTOR VIII with VON WILLIBRAND FACTOR 250 IU (contains Factor VIII 250 IU along with minimum 50% of VWF)

1,700

1 No

2,499

₹2,623.95

6.5

₹6.83

Lowest

2.00

ANTI HAEMOPHILIC FACTOR VII 1 mg (50,000 IU)

500

1 No

38,027

₹39,928.35

Lowest

3.00

HUMAN ANTI HAEMOPHILIC FACTOR IX 500IU/600 IU

4,500

1 No

3,894

₹4,088.7

Lowest

4,920

₹5,166

4.00

FACTOR VIII INHIBITOR BYPASSING AGENT (FEIBA) 500 U

1,000

1 No

30,000

₹31,500

Lowest